Diagnostic accuracy of 18F-FDG and 11C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment

被引:88
作者
Zhang, S. [1 ]
Han, D. [1 ]
Tan, X. [1 ]
Feng, J. [1 ]
Guo, Y. [1 ]
Ding, Y. [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Neurol, Shenyang 110023, Liaoning, Peoples R China
关键词
PITTSBURGH COMPOUND-B; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL AMYLOID ANGIOPATHY; GLUCOSE-METABOLISM; APOLIPOPROTEIN-E; FDG-PET; CLINICAL PROGRESSION; APOE GENOTYPE; F-18-FDG PET; PIB-PET;
D O I
10.1111/j.1742-1241.2011.02845.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years, the role of PET imaging in the prediction of mild cognitive impairment (MCI) to Alzheimers disease (AD) conversion has been the subject of many longitudinal studies. The purpose of this study was to perform a meta-analysis to estimate the diagnostic accuracy of 18F-fluoro-2-deoxyglucose-positron emission tomography (FDG-PET) and 11C-Pittsburgh Compound B-positron emission tomography (PIB-PET) for prediction of short-term conversion to AD in patients with MCI. The MEDLINE and EMBASE databases were systematically searched for relevant studies. Methodological quality of the included studies was assessed. Sensitivities and specificities of PET in individual studies were calculated and meta-analysis was undertaken with a random-effects model. A summary receiver operating characteristic (SROC) curve was constructed with the MosesShapiroLittenberg method. Heterogeneity was tested, and the presence of publication bias was assessed. Potential sources for heterogeneity were explored by assessing whether or not certain covariates significantly influenced the relative diagnostic odds ratio (DOR). Pooled estimates of sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR), DOR and the SROC curve of each PET imaging were determined. A total of 13 research studies (seven FDG-PET and six PIB-PET) met inclusion criteria and had sufficient data for statistical analysis. FDG-PET pooled estimates had 78.7% sensitivity (95% CI, 68.786.6%),74.0% specificity (95% CI, 67.080.3%), 18.1 LR+(95% CI, 7.345.0) and 0.32 LR(95% CI, 0.160.61); and PIB-PET pooled estimates had 93.5% sensitivity (95%CI, 71.399.9%), 56.2% specificity (95% CI, 47.264.8%), 2.01 LR+ (95% CI, 1.572.58) and 0.17 LR(95% CI, 0.080.36). Overall DOR was 17.3 (95% CI, 5.0859.2) for FDG-PET and 12.8 (95% CI, 5.3530.54) for PIB-PET. Area under the SROC curve was 0.88 +/- 0.05 for FDG-PET and 0.85 +/- 0.04 for PIB-PET. The data from FDG-PET research studies had high heterogeneity and funnel plot suggested a publication bias. The diagnostic accuracy determined for both FDG-PET and PIB-PET in this meta-analysis suggests that they are potentially valuable techniques for prediction of progression in patients with MCI. Both have their advantages and their combined use is a promising option for prediction purposes depending on availability and experience.
引用
收藏
页码:185 / 198
页数:14
相关论文
共 52 条
[1]   The apolipoprotein E ε4 allele and incident Alzheimer's disease in persons with mild cognitive impairment [J].
Aggarwal, NT ;
Wilson, RS ;
Beck, TL ;
Bienias, JL ;
Berry-Kravis, E ;
Bennett, DA .
NEUROCASE, 2005, 11 (01) :3-7
[2]   Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly [J].
Aizenstein, Howard Jay ;
Nebes, Robert D. ;
Saxton, Judith A. ;
Price, Julie C. ;
Mathis, Chester A. ;
Tsopelas, Nicholas D. ;
Ziolko, Scott K. ;
James, Jeffrey A. ;
Snitz, Beth E. ;
Houck, Patricia R. ;
Bi, Wenzhu ;
Cohen, Ann D. ;
Lopresti, Brian J. ;
DeKosky, Steven T. ;
Halligan, Edythe M. ;
Klunk, William E. .
ARCHIVES OF NEUROLOGY, 2008, 65 (11) :1509-1517
[3]   Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease [J].
Anchisi, D ;
Borroni, B ;
Franceschi, M ;
Kerrouche, N ;
Kalbe, E ;
Beuthien-Beumann, B ;
Cappa, S ;
Lenz, O ;
Ludecke, S ;
Marcone, A ;
Mielke, R ;
Ortelli, P ;
Padovani, A ;
Pelati, O ;
Pupi, A ;
Scarpini, E ;
Weisenbach, S ;
Herholz, K ;
Salmon, E ;
Holthoff, V ;
Sorbi, S ;
Fazio, F ;
Perani, D .
ARCHIVES OF NEUROLOGY, 2005, 62 (11) :1728-1733
[4]  
[Anonymous], 2011, IEEE 27 CONV EL EL E
[5]   Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment [J].
Arnáiz, E ;
Jelic, V ;
Almkvist, O ;
Wahlund, LO ;
Winblad, B ;
Valind, S ;
Nordberg, A .
NEUROREPORT, 2001, 12 (04) :851-855
[6]   Mild cognitive impairment -: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? [J].
Chételat, G ;
Desgranges, B ;
de la Sayette, V ;
Viader, F ;
Eustache, F ;
Baron, JC .
NEUROLOGY, 2003, 60 (08) :1374-1377
[7]   Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates [J].
Cole, Graham B. ;
Keum, Gyochang ;
Liu, Jie ;
Small, Gary W. ;
Satyamurthy, Nagichettiar ;
Kepe, Vladimir ;
Barrio, Jorge R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (14) :6222-6227
[8]   Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET) [J].
de Leon, MJ ;
Convit, A ;
Wolf, OT ;
Tarshish, CY ;
DeSanti, S ;
Rusinek, H ;
Tsui, W ;
Kandil, E ;
Scherer, AJ ;
Roche, A ;
Imossi, A ;
Thorn, E ;
Bobinski, M ;
Caraos, C ;
Lesbre, P ;
Schlyer, D ;
Poirier, J ;
Reisberg, B ;
Fowler, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) :10966-10971
[9]   Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia [J].
DeCarli, C ;
Mungas, D ;
Harvey, D ;
Reed, B ;
Weiner, M ;
Chui, H ;
Jagust, W .
NEUROLOGY, 2004, 63 (02) :220-227
[10]   Systematic reviews in health care - Systematic reviews of evaluations of diagnostic and screening [J].
Deeks, JJ .
BRITISH MEDICAL JOURNAL, 2001, 323 (7305) :157-162